Vimeo
LinkedIn
Instagram
Share |

bonderman family david bonderman

May 10, 2016

Wildcat Capital, which manages funds for the American billionaire David Bonderman, has called for management changes at a pharmaceutical firm, representing a rare public case of shareholder activism by a family office.

Wildcat Capital, which manages funds for the American billionaire David Bonderman, has called for management changes at a pharmaceutical firm, representing a rare public case of shareholder activism by a family office.

In a strongly worded letter, Wildcat raised concerns over corporate governance at Sorrento Therapeutics and said the chief executive, Henry Ji, should be replaced.

Click here >>
Close